SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Novartis Pharmaceuticals Canada Inc. Release: Canadian Agency for Drugs and Technologies in Health (CADTH) Recommends Provincial and Publicly Funded Drug Plans Reimburse (Pr)Lucentis* to Treat Vision Loss Resulting From Diabetic Macular Edema (DME)